Gregory Friberg
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Gregory Friberg
The proxy statement of Biomarin Pharmaceutical Inc reports total compensation of $7,174,583 for Gregory Friberg in fiscal 2025, including a base salary of $705,654. Disclosed compensation is on record for 2 fiscal years. Gregory Friberg has spoken on 2 earnings calls across 1 company, most recently for Biomarin Pharmaceutical Inc on August 6, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Biomarin Pharmaceutical Inc (BMRN)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Biomarin Pharmaceutical Inc
Other people whose current roles at this company are on record from its filings.
- Alexander Hardy CEO, Board Member
- Richard A. Meier Chairman
- Brian Mueller CFO
- Daniel Spiegelman CFO
- Dr. C. Greg Guyer CTO
- G. Eric Davis General Counsel
- Andrea Acosta Chief Accounting Officer
- Rashmi Ramchandani Chief Accounting Officer
- Athena Countouriotis Board Member
- Barbara Bodem Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Biomarin Pharmaceutical Inc (BMRN) | Executive Vice President, Chief Research & Development Officer — | $705,654 | $7,174,583 |
| 2024 | Biomarin Pharmaceutical Inc (BMRN) | Executive Vice President, Chief Research & Development Officer — — | $161,538 | $7,221,559 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.